BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1445742)

  • 1. Prognosis of lymphoma from a fine-needle aspirate.
    Joensuu H; Alanen K; Klemi PJ
    Eur J Cancer; 1992; 29A(1):29-33. PubMed ID: 1445742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
    Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
    J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma.
    Joensuu H; Klemi PJ; Söderström KO; Jalkanen S
    Cancer; 1991 Oct; 68(7):1564-71. PubMed ID: 1893358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA content analysis of fine needle aspirates obtained from lymphatic tissue.
    Alanen KA; Joensuu H; Klemi PJ
    Anal Quant Cytol Histol; 1993 Aug; 15(4):259-64. PubMed ID: 8397647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
    Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
    Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma.
    Jalkanen S; Joensuu H; Klemi P
    Blood; 1990 Apr; 75(7):1549-56. PubMed ID: 2180497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study.
    Joensuu H; Klemi PJ; Jalkanen S
    Cancer; 1990 Jun; 65(11):2564-71. PubMed ID: 2337874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilution effect of nontumor cells on flow cytometric DNA S-phase fraction in breast cancer fine needle aspirates.
    Gazic B; Pizem J; Us-Krasovec M
    Anal Quant Cytol Histol; 2005 Oct; 27(5):277-83. PubMed ID: 16447820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma.
    Wu HM
    J Tongji Med Univ; 1992; 12(2):65-70. PubMed ID: 1433420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation in non-Hodgkin's lymphomas and its prognostic value related to staging parameters.
    Lorand-Metze I; Pereira FG; Costa FP; Metze K
    Cell Oncol; 2004; 26(1-2):63-71. PubMed ID: 15371658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of DNA flow cytometry combined with fine needle aspiration biopsy in lymphomas.
    Joensuu H; Klemi PJ; Eerola E
    J Pathol; 1988 Mar; 154(3):237-45. PubMed ID: 3351670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
    De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
    Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic, predictive and prognostic verification of DNA flow cytometric measurements performed at diagnosis for non-Hodgkin's lymphoma adult patients.
    Lackowska B; Gruchała A; Jaszcz-Gruchała A; Rolski J; Zemełka T; Dańda D; Ryś J
    Pol J Pathol; 2012 Mar; 63(1):18-24. PubMed ID: 22535602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of cell proliferation by Ki-67 staining and flow cytometry in fine needle aspirates (FNAs) of reactive lymphadenitis and non-Hodgkin's lymphomas.
    Schmitt F; Tani E; Tribukait B; Skoog L
    Cytopathology; 1999 Apr; 10(2):87-96. PubMed ID: 10211614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma.
    Vielh P; Carton M; Padoy E; de Rycke Y; Klijanienko J; El-Naggar AK; Asselain B
    Cancer; 2005 Dec; 105(6):476-82. PubMed ID: 16116603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent prognostic value of hormone receptor expression and S-phase fraction in advanced breast cancer.
    Pinto AE; Mendonça E; André S; Nóbrega SD; Soares J
    Anal Quant Cytol Histol; 2002 Dec; 24(6):345-54. PubMed ID: 12508694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric lymphomas in Turkey. Analysis of prognostic factors with special emphasis on flow cytometric DNA content.
    Aydin ZD; Barista I; Canpinar H; Sungur A; Tekuzman G
    Cancer; 2000 Jul; 89(1):12-20. PubMed ID: 10896995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.